Showing results (1041-1050 of 1,142) with videos related to
Sort By:
Pageof 115
JHEP Reports : Innovation in Hepatology|June 17, 2025
Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosisJim Benjamin Mauz, Lukas Hartl, Andrea Kornfehl, et al.JAMA|December 27, 2012
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosisAdriaan J van der Meer, Bart J Veldt, Jordan J Feld, et al.Gastroenterology|March 25, 2014
Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infectionAdrian M Di Bisceglie, Ewa Janczweska-Kazek, François Habersetzer, et al.Scientific Reports|September 11, 2023
Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota compositionIda Søgaard Larsen, Megan Chenaux, Fergus W J Collins, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 9, 2024
Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48Tarik Asselah, Pietro Lampertico, Soo Aleman, et al.Journal of Viral Hepatitis|March 26, 2017
Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C RegistryT M Welzel, H Hinrichsen, C Sarrazin, et al.Hepatology (Baltimore, Md.)|July 9, 2017
Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failureDavid Wyles, Heiner Wedemeyer, Ziv Ben-Ari, et al.Journal of Viral Hepatitis|November 13, 2020
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reductionOlympia E Anastasiou, Cihan Yurdaydin, Benjamin Maasoumy, et al.The Lancet. Infectious Diseases|March 26, 2013
Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trialKatja Deterding, Norbert Grüner, Peter Buggisch, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 6, 2021
Liver-first strategy for a combined lung and liver transplant in patients with cystic fibrosisKhalil Aburahma, Jawad Salman, Bastian Engel, et al.Pageof 115